Bertrand Jaber, MD, MSc, FASN, FNKF
Adjunct Professor, Medicine
Biography
Dr. Jaber is the Chair of Medicine and a board-certified internist and nephrologist. He serves as Chair of the Clinical Competency Committee, and Core Faculty for the Internal Medicine Residency Program. Dr. Jaber received his medical degree from St. Joseph University Faculty of Medicine, Beirut, Lebanon, and completed a residency in Internal Medicine at Carney Hospital, Boston, MA, followed by a clinical and research fellowship in nephrology at Tufts New England Medical Center, Boston, MA. He also holds a Master of Science in Clinical Research from the Graduate School of Biomedical Sciences at Tufts University.
Dr. Jaber has had a longstanding commitment to medical education. Over the years, he has been the recipient of numerous teaching awards and citations from medical students and residents, including the St. Luke’s Award in recognition of his dedication and excellence to the education of residents. Dr. Jaber is a member of the Intern Selection Committee and participates extensively in lecture instructions and in hospital- and clinic-based teaching of residents. He also directs the Quality Improvement Curriculum of the residency program.
Dr. Jaber’s research interests and original accomplishments have covered several important areas within the field of nephrology, including biocompatibility of dialyzers, leukocyte dysfunction in uremia, novel dialysis therapies, and the utility of biomarkers in acute kidney injury. He has also made contributions to the field of evidence-based medicine through the conduct of meta-analyses on the prevention and treatment of kidney diseases. He has mentored and supervised scores of trainees through the conduct of quality improvement initiatives and research projects.
Websites
Education
- St. Joseph's University, MD
- Tufts University, MSc
- Collège Mont La Salle, BS
Publications
- Published on 2/1/2025
Mughrabi A, Maamari J, Phillips T, Alabbasi A, Brooks A, Nuriev R, Zenkin L, Jaber BL, Nader C. Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study. Int J Clin Pharmacol Ther. 2025 Feb; 63(2):54-62. PMID: 39744800.
Read at: PubMed - Published on 1/10/2025
Alhaddad J, Allos H, Dimitrov D, Nader CM, Rennke HG, Jaber BL. Minimal change disease in treatment-naïve hepatitis C virus infection: A case report and literature review. Clin Nephrol Case Stud. 2025; 13:1-7. PMID: 39816676.
Read at: PubMed - Published on 7/23/2024
Alabdul Razzak I, Korchemny N, Smoot D, Jose A, Jones A, Price LL, Jaber BL, Moraco AH. Parameters Predictive of Propofol-Associated Acute Pancreatitis in Critically Ill Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. J Intensive Care Med. 2025 Jan; 40(1):67-73. PMID: 39043370.
Read at: PubMed - Published on 6/7/2024
Philipp M, Tessier A, Donnelly M, Fang L, Feng K, Zhao L, Grosser S, Sun G, Sun W, Mentré F, Bertrand J. Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging? Stat Med. 2024 Aug 15; 43(18):3403-3416. PMID: 38847215.
Read at: PubMed - Published on 6/6/2024
Guhl M, Bertrand J, Fayette L, Mercier F, Comets E. Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. AAPS J. 2024 Jun 06; 26(4):64. PMID: 38844645.
Read at: PubMed - Published on 6/5/2024
Baudemont G, Tardivon C, Monneret G, Cour M, Rimmelé T, Garnier L, Yonis H, Richard JC, Coudereau R, Gossez M, Wallet F, Delignette MC, Dailler F, Buisson M, Lukaszewicz AC, Argaud L, Laouenan C, Bertrand J, Venet F. Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients. CPT Pharmacometrics Syst Pharmacol. 2024 Jul; 13(7):1130-1143. PMID: 38837680.
Read at: PubMed - Published on 5/11/2024
Delgado T, Veselá D, Dostálová H, Kryštof V, Vojácková V, Jorda R, Castro A, Bertrand J, Rivera G, Faúndez M, Strnad M, Espinosa-Bustos C, Salas CO. New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024 May 11; 16(5). PMID: 38794311.
Read at: PubMed - Published on 5/11/2024
Stücker S, Koßlowski F, Buchholz A, Lohmann CH, Bertrand J. High frequency of BCP, but less CPP crystal-mediated calcification in cartilage and synovial membrane of osteoarthritis patients. Osteoarthritis Cartilage. 2024 Dec; 32(12):1542-1551. PMID: 38735362.
Read at: PubMed - Published on 4/23/2024
Guhl M, Bertrand J, Fayette L, Mercier F, Comets E. Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm. AAPS J. 2024 Apr 23; 26(3):53. PMID: 38722435.
Read at: PubMed - Published on 3/27/2024
Bergmann M, Fakhoury B, Barroso T, Prushik SG, Jaber BL, Balakrishnan VS. Early access flow rate predicts vascular access patency-related intervention in the first year: A retrospective cohort study. Hemodial Int. 2024 Jul; 28(3):262-269. PMID: 38533534.
Read at: PubMed
View 178 more publications: View full profile at BUMC